Member Info for SGD27

Portfolio B includes "unlisted and certain highly illiquid listed assets" :

https://equityincome.linkfundsolutions.co.uk/investor-communications/friday-13th-december-2019-investor-letter-regarding-the-winding-up-of-the-lf-equity-income-fund/

My guess is that the definition of "illiquid" will be the pragmatic one suggested by TruthSearcher, i.e. difficult to sell what they've got, so would likely include TRX.

@B2HS2L, I can't answer your question about TR1s, but this may (or may not) be relevant :

https://www.thetimes.co.uk/article/wg-partners-races-to-save-neil-woodford-science-start-ups-mmhrmvq0q

https://www.vo%78markets.co.uk/articles/arix-bioscience-and-shield-therapeutics-87ca6ba

discussing today's Quench Bio RNS.

Picked up by SamJSung on the SNG board, and relevant here :

https://www.thetimes.co.uk/article/wg-partners-races-to-save-neil-woodford-science-start-ups-mmhrmvq0q

"
The proposed buyer of stakes in 20 start-ups held by fallen fund manager Neil Woodford is rushing to secure money before a crunch deadline.

WG Partners, a boutique bank, has been trying to raise about £550m before a period of exclusive talks to acquire the portfolio runs out at the end of this month — although it could seek an extension.

The holdings — which include stakes in Oxford Nanopore, Arix Bioscience and Immunocore — formed a large part of Woodford’s life sciences interests.

...

"

Thanks Sam, that's very useful info.

I agree that it quite likely includes SNG: "The holdings — which include stakes in Oxford Nanopore, Arix Bioscience and Immunocore — formed a large part of Woodford’s life sciences interests."

So now the question arises - what does "peak worth" refer to? I guess it might mean the value just prior to the Woodford downfall, which for SNG would be around 13-14p. Multiplying by 55% then gives around 7-8p which is roughly where we are now, so it does make some kind of sense (albeit a significant undervaluation of the "true" value IMO).

Here's a link BTW, though the full article is for subscribers only (which I'm not) :

https://www.thetimes.co.uk/article/wg-partners-races-to-save-neil-woodford-science-start-ups-mmhrmvq0q

The CS Project web page has been updated. The bit about targeting permitting in Q4 2019 has been removed, not surprisingly, but no new date has been given.

@rodster I'd also be interested in where you read the June date?

https://www.sunriseresourcesplc.com/cs-project

Hi Rich, you did see that it was a delayed trade?

Working OK when I tried it just now.

OK, but it does mean they _might_ still try to sell all or part of the SNG shares in time for the (revised) first pay-out date.

As an aside, does anyone know if there's a list somewhere of what shares are in Portfolio A vs B?

There appears to be a 10 day delay :

https://equityincome.linkfundsolutions.co.uk/investor-communications/friday-10th-january-2020-investor-letter-regarding-the-winding-up-of-the-lf-equity-income-fund/

https://uk.ad%76fn.com/stock-market/london/sunrise-resources-SRES/share-chat

If it's out of date, try your 'refresh' button?

Hi Sam, yes, that is an interesting idea. They would have to get it across the US-6 road though - not sure how big a problem that would be.

I wonder if some sort of electric trucks might work well over that kind of distance?

He might just be raising cash to buy other shares which are at bargain prices due to the Woodford debacle (e.g. SNG where he already has an interest).

For those speculating on whether Richard Griffiths may be buying in here, I note that he's reducing elsewhere, which suggests it's a possibility:

https://www.investegate.co.uk/horizonte-minerals--hzm-/rns/holding-s--in-company/202001070700098832Y/

Interesting - on HL I can now apparently buy 10k @ 6p, or sell 10k @6.0125p !

Pharmaxis down 40% not surprisingly, and seems to be having a knock-on effect on our SP.

Anyone thinking of bidding for the Woodford shares must be quite happy :-(

& now Harpoon Therapeutics :

https://www.brrmedia.co.uk/broadcasts/5d9f467e34a3cf1389e7d24d/arix-bioscience-interview-with-harpoon-therapeutics-ceo-jerry-mcmahon

Pharmaxis not doing too well though :-(

& presumably more TR1s to follow soon.

Welcome Ade3,
The blue/red indication is just an automated thing. If the trade price is nearer the Bid price than the Ask price then it's guessed to be a sell. So you could say it means you got a good price both times :-)

https://www.brrmedia.co.uk/broadcasts/5d9f425f34a3cf1389e7d15f/arix-bioscience-interview-with-aura